You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: long-term β-blocker use reduces mortality after myocardial infarction

https://doi.org/10.1136/ebm.5.1.12

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: SmithKline Beecham Pharmaceuticals UK.

    • For correspondence: Dr N Freemantle, Medicines Evaluation Group, Centre for Health Economics, University of York, York, YO10 5DD, UK. FAX +44-(0)1904-434568